Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Neoplasms 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Healthy Participants 2 Advanced Solid Tumor 2 cMET-dysregulated Advanced Solid Tumors 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Solid Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Liver Cirrhosis 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Head and Neck Neoplasms 1 Drug-drug Interaction,SHR3680 1 Colorectal Neoplasms 1 Advanced Solid Malignancies 1 Advanced Pancreatic Cancer 1

Interventions

Doxorubicin 127 Ifosfamide 76 Radiotherapy 73 Cyclophosphamide 64 Gemcitabine 54 Filgrastim 48 pazopanib 38 pembrolizumab 36 Trabectedin 36 Etoposide 36 Docetaxel 35 Vincristine 34 Cisplatin 30 Nivolumab 29 Magnetic Resonance Spectroscopy 23 Irinotecan 23 Carboplatin 22 Temozolomide 20 Surgical Procedures, Operative 20 Radiation 20 Ipilimumab 20 Mesna 17 Granulocyte Colony-Stimulating Factor 17 Biopsy 17 Bevacizumab 17 Sirolimus 16 Melphalan 16 Blood Specimen Collection 16 eribulin 15 anlotinib 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03016819 2026-02-25

APROMISS

Advenchen Laboratories, LLC

Phase 3 Recruiting

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡